when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

ELI LILLY CO · news · pharmadog

← back to ELI LILLY CO

News mentioning ELI LILLY CO

230 stories

Jun 29, 26STAT+: 26 states sue to block Medicaid work requirementsstat

Jun 29, 265 takeaways from STAT’s investigation into microhospital operator Nutex Healthstat

Jun 29, 26STAT+: Longevity, wellness physicians named to panel advising FDA on peptidesstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 26, 26FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesbiopharma dive

Jun 26, 26Alkermes’ incoming CEO has a plan to outplay Lilly and Takedabiopharma dive

Jun 26, 26On second try, Acadia drug gets nod from European regulatorsbiopharma dive

Jun 19, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jun 18, 26STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims datastat

Jun 18, 26STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims datastat

Jun 18, 26STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and morestat

Jun 18, 26Eli Lilly's TuneLab hits 100 members, adding Chai's AI modelsendpoints

Jun 18, 26What’s next for GLP-1 weight loss drugs?stat

Jun 17, 26Jazz zeroes in on next-gen T cell engagers with AbCellera dealbiopharma dive

Jun 17, 26STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcommstat

Jun 16, 26Lilly buys non-opioid pain drugmaker 4Ebiopharma dive

Jun 16, 26Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pillendpoints

Jun 16, 26STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and morestat

Jun 16, 26STAT+: Verge Labs’ new AI model solves patient stratification problems for neurology clinical trialsstat

Jun 15, 26Lilly scores early positive data for new JAK drugbiopharma dive

Jun 15, 26Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutendpoints

Jun 12, 26Eli Lilly invests in startup Abridge for clinical trial recruitmentendpoints

Jun 12, 26STAT+: Prometheus raises $12 billion in capital for artificial engineersstat

Jun 11, 26STAT+: Abridge inks deals with Nvidia and Lillystat

Jun 11, 26STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and morestat

Jun 10, 26AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicinebiopharma dive

Jun 9, 26Eli Lilly's claims data deadline may kick off new 340B fightendpoints

Jun 9, 26Stealthy startup Treeline plans a reverse mergerbiopharma dive

Jun 9, 26Gilead and Merck’s latest trial success and flopstat

Jun 8, 26STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trialsstat

← prevpage 5 of 8next →